Pilihan
Acronis Launches GenAI Protection, Enabling MSPs to Secure and Govern AI Usage
New solution provides visibility, control, and protection for generative AI adoption, designed for MSPs
SCHAFFHAUSEN, Switzerland, April 22, 2026 (GLOBE NEWSWIRE) -- Acronis, a global leader in cyber protection, today announced the launch of Acronis GenAI Protection, a monitoring and security solution that enables managed service providers (MSPs) to control generative AI usage across client environments, preventing sensitive data exposure and protecting against malicious prompt manipulation.
Acronis GenAI Protection represents the initial phase of Acronis Cyber Workspace, with additional capabilities planned for release to deliver a protected AI workspace, natively integrated into the Acronis platform.
As organizations rapidly adopt generative AI tools, businesses face growing risks related to data leakage, shadow AI usage, and malicious prompt manipulation. Many consumer-grade AI tools lack enterprise visibility, while enterprise solutions are not designed to be delivered and managed through MSPs. Acronis GenAI Protection addresses this gap by providing partners with a purpose-built solution to monitor and secure generative AI usage across SMB environments.
Acronis GenAI Protection
AI Monitoring and Security Delivered Through MSPs
Acronis GenAI Protection is designed to be provisioned, managed, and monetized by MSPs. Through a centralized console integrated into the Acronis platform, service providers can monitor AI usage across customer environments, including policy enforcement, reporting, and risk mitigation, while protecting generative AI interactions alongside data, applications, and endpoints.
"Generative AI adoption is accelerating, but it introduces new risks that businesses are not fully equipped to manage," said Gaidar Magdanurov, President at Acronis. "MSPs are uniquely positioned to help businesses adopt AI securely, but until now they haven't had the right tools to monitor and manage it effectively. GenAI Protection enables MSPs to turn AI security into a managed service, creating new revenue opportunities while protecting their customers from emerging risks."
Built-In Protection for Generative AI Usage
Acronis GenAI Protection provides visibility and security for AI usage without requiring additional point solutions or enterprise-grade complexity.
Key capabilities include:
Shadow AI usage and visibility: Discover and monitor generative AI applications used across client environments to understand adoption and risk exposure.
Sensitive data protection for AI interactions: Inspect prompts for sensitive data such as PII or PHI and prevent unauthorized transmission to public or unsanctioned AI tools.
Prompt injection and AI abuse prevention: Detect and block malicious prompts designed to manipulate AI behavior or compromise workflows.
"AI is now mainstream for SMBs, with over half using AI tools, led by marketing and sales seeking scale, productivity, and efficiency," said Matthew Ball, Chief Analyst at Omdia. "While most adoption runs through SaaS, growing use of consumer AI, sanctioned or not, generates new security risks that create new requirements for MSPs to actively manage."
As AI continues to evolve, Acronis plans to introduce additional AI-powered capabilities to protect, manage, and automate AI services and tools within its broader Cyber Workspace offering. These enhancements are designed to boost productivity and automation, enabling MSPs to streamline day-to-day operations while strengthening data and asset protection.
Acronis GenAI Protection is now generally available globally.
To learn more, visit the announcement blog here: https://www.acronis.com/en/blog/posts/acronis-genai-protection-is-now-live-secure-the-ai-era/
For more information about Acronis GenAI Protection, visit: https://www.acronis.com/en/products/cloud/cyber-protect/genai-protection/
About Acronis:
Acronis is a global cyber protection company delivering the only natively integrated cybersecurity, data protection, and infrastructure management platform for managed service providers and IT departments. Acronis solutions are designed to identify, protect, detect, respond, recover and govern IT deployments, ensuring data integrity and business continuity.
A Swiss company founded in Singapore in 2003, Acronis has 15 offices worldwide and employees in 60+ countries. Acronis Cyber Platform is available in 26 languages in 150 countries and is used by over 21,000 service providers to protect over 750,000 businesses. Learn more at www.acronis.com.
Acronis Press Contact:
Julia Carfagno
Senior Global Communications Manager
Julia.Carfagno@acronis.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c95d96ce-8d59-4996-b1ad-c85aaa88c483
Copyright 2026 GlobeNewswire, Inc.
.png)

Berita Lainnya
Zymeworks Announces Participation in Upcoming Investor Conferences
Aptiv achieves lowest lost-workday case rate in 15 years following global EHS+ transformation with Cority
Wood Mackenzie: Falling fertility rates threaten long-term energy demand as global population could peak at 8.9 billion by 2053
DutyFreeFood.com Membuka Pendaftaran Vendor & Investor Global Menjelang Peluncuran Pasar Online Bebas Bea untuk Makanan, Minuman Beralkohol & Minuman Lainnya Pertama di Dunia pada Musim Gugur 2026
HKC and ANTGAMER Wrap Up 2026 HKTDC Fair as Fate Trigger Collaboration Draws Strong Attention
SpaceX Resmi Tercatat di Bursa: SPCX Kini Tersedia untuk Diperdagangkan Setelah Debut Bersejarah di Nasdaq
98% Say Agentic AI to Speed Software Delivery from ‘Pilot Purgatory’ in New Report by SoftServe and MIT Technology Review
Hong Kong and New Zealand among the 10 easiest jurisdictions to do business in, says the GBCI 2026
Accion celebrates 65 years of its work connecting low-income communities to responsible financial services
China's 15th Five-Year Plan: Charting Solutions in an Uncertain World
Booster Robotics' Humanoid Robots Claim All Championship Titles at RoboCup 2026
Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026